Your browser is no longer supported. Please, upgrade your browser.
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E16.10 EPS (ttm)2.38 Insider Own0.20% Shs Outstand2.50B Perf Week-1.39%
Market Cap96.94B Forward P/E12.30 EPS next Y3.12 Insider Trans0.00% Shs Float2.48B Perf Month-6.62%
Income6.02B PEG3.66 EPS next Q0.86 Inst Own13.00% Short Float0.66% Perf Quarter-3.49%
Sales45.12B P/S2.15 EPS this Y23.20% Inst Trans3.27% Short Ratio4.53 Perf Half Y4.69%
Book/sh8.43 P/B4.55 EPS next Y-0.10% ROA5.50% Target Price48.04 Perf Year2.70%
Cash/sh1.93 P/C19.84 EPS next 5Y4.40% ROE29.70% 52W Range33.26 - 42.68 Perf YTD4.32%
Dividend2.17 P/FCF64.02 EPS past 5Y-7.90% ROI17.30% 52W High-9.65% Beta0.69
Dividend %5.65% Quick Ratio0.50 Sales past 5Y7.30% Gross Margin67.70% 52W Low15.94% ATR0.50
Employees94066 Current Ratio0.80 Sales Q/Q6.10% Oper. Margin19.10% RSI (14)32.45 Volatility1.14% 1.01%
OptionableYes Debt/Eq1.66 EPS Q/Q-38.80% Profit Margin13.30% Rel Volume0.68 Prev Close38.39
ShortableYes LT Debt/Eq1.33 EarningsJul 28 BMO Payout50.60% Avg Volume3.60M Price38.56
Recom2.00 SMA20-3.46% SMA50-4.39% SMA2000.88% Volume2,029,445 Change0.45%
Jun-24-21Upgrade Deutsche Bank Sell → Hold
Mar-23-21Downgrade SVB Leerink Outperform → Mkt Perform
Feb-04-21Downgrade Deutsche Bank Hold → Sell
Jan-20-21Downgrade Credit Suisse Neutral → Underperform
Jan-15-21Initiated Deutsche Bank Hold
Nov-02-20Upgrade Liberum Hold → Buy
Sep-29-20Initiated Berenberg Buy
Feb-12-20Downgrade Shore Capital Hold → Sell
Jan-16-20Downgrade Barclays Equal Weight → Underweight
Dec-02-19Initiated SVB Leerink Outperform
Nov-21-19Upgrade UBS Neutral → Buy
Oct-11-19Upgrade Cantor Fitzgerald Hold → Buy
Sep-03-19Upgrade Societe Generale Sell → Buy
Sep-03-19Resumed Citigroup Neutral
Aug-13-19Resumed JP Morgan Neutral
Jun-17-19Resumed Morgan Stanley Underweight
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Dec-11-18Resumed Jefferies Buy
Sep-27-21 02:36PM  
08:50AM  
Sep-24-21 02:02PM  
06:02AM  
06:00AM  
Sep-23-21 05:11PM  
02:22PM  
06:00AM  
06:00AM  
04:23AM  
Sep-22-21 01:43PM  
12:32PM  
06:00AM  
Sep-21-21 11:18AM  
Sep-20-21 01:42PM  
08:12AM  
Sep-18-21 07:03AM  
Sep-17-21 03:59PM  
03:56PM  
02:09PM  
07:58AM  
Sep-15-21 01:51PM  
Sep-13-21 01:40PM  
Sep-10-21 05:52AM  
Sep-09-21 02:24PM  
Sep-08-21 03:20PM  
01:37PM  
Sep-07-21 04:05PM  
02:12PM  
12:01AM  
Sep-03-21 01:58PM  
09:44AM  
Sep-02-21 05:50PM  
02:18PM  
Sep-01-21 07:01PM  
02:14PM  
12:47PM  
Aug-31-21 07:12AM  
02:59AM  
Aug-30-21 02:06PM  
Aug-28-21 06:28AM  
Aug-27-21 02:07PM  
Aug-25-21 01:38PM  
Aug-24-21 02:16PM  
07:47AM  
Aug-23-21 01:57PM  
04:18AM  
Aug-20-21 02:54PM  
08:23AM  
Aug-19-21 03:01PM  
07:37AM  
05:52AM  
Aug-18-21 02:06PM  
01:31PM  
01:26PM  
11:04AM  
07:37AM  
Aug-17-21 10:56AM  
09:58AM  
Aug-16-21 01:50PM  
10:30AM  
05:01AM  
Aug-13-21 02:05PM  
Aug-12-21 02:11PM  
11:29AM  
Aug-11-21 05:00PM  
02:20PM  
10:56AM  
Aug-10-21 09:45AM  
Aug-09-21 02:16PM  
Aug-06-21 02:08PM  
10:20AM  
Aug-05-21 01:47PM  
Aug-04-21 02:12PM  
Aug-03-21 02:25PM  
Aug-02-21 01:55PM  
01:45PM  
08:08AM  
Aug-01-21 02:52PM  
Jul-30-21 01:56PM  
11:28AM  
10:12AM  
07:51AM  
Jul-29-21 06:03PM  
02:06PM  
12:58PM  
11:03AM  
Jul-28-21 06:00PM  
01:51PM  
11:07AM  
09:11AM  
08:51AM  
08:28AM  
07:25AM  
07:09AM  
06:47AM  
06:20AM  
03:36AM  
Jul-27-21 02:12PM  
11:14AM  
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerJul 02Buy18.00275,0004,950,0001,007,583Jul 06 04:38 PM
GLAXOSMITHKLINE PLC10% OwnerMay 20Sale12.2532,005,260392,064,4350May 24 05:04 PM